$XOMA

XOMA Corp

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$19.41 ▼-0.564%

Extented Hours

VOLUME

65,078

DAY RANGE

19.22 - 22

52 WEEK

15.68 - 32.09

Join Discuss about XOMA with like-minded investors

profile
@dros #droscrew
recently

Upgrades 9/7: $BMO $CRUS $DOOO $FIVN $MEOH $SO $SPOT $TCBK $TD $TMX $VTR . Downgrades 9/7: $AMCR $AMGN $ARGX $BANR $CARR $FTCH $GMAB $JNJ $JOAN $LNT $LRCX $MCFE $MRK $SJR $VRTX $XOMA

69 Replies 14 👍 14 🔥

Key Metrics

Market Cap

241.15 M

Beta

0.74

Avg. Volume

18.32 K

Shares Outstanding

11.45 M

Yield

0%

Public Float

0

Next Earnings Date

2023-03-09

Next Dividend Date

Company Information

XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company's portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. Many of these licenses are the result of XOMA's pioneering efforts in the discovery and development of antibody therapeutics. The Company's royalty-aggregator business model includes acquiring additional licenses to programs with third-party funding.

CEO: James Neal

Website:

HQ: 2200 Powell St Ste 310 Emeryville, 94608-1818 California

Related News